A Novel Fine Granule System for Masking Bitter Taste
スポンサーリンク
概要
- 論文の詳細を見る
In order to prepare fine granules of sparfloxacin (SPFX), a new quinolone anti-bacterial drug that shows masking of the bitter taste of SPFX and dissolutes at a rapid rate, various film-coated fine granules containing 20% SPFX and 0-52% low-substituted hydroxypropylcellulose(L-HPC) in the cores, were prepared by a spray method. Mixtures of ethylcellulose (EC), hydroxypropylmethylcellulose (HPMC), titanium dioxide and sucrose stearate in weight ratios of X : Y : 2 : 1 (X+Y=6) were used as film materials.The degree of masking of the bitter taste by water-insoluble film, mainly consisting of EC and HPMC, increased by increasing the content ratio of EC to HPMC and the amount of films, but was also slightly affected by the amount of L-HPC in the cores, which were coated with either EC or EC/HPMC (4/2). On the other hand, the dissolution rate increased with an increased amount of L-HPC in the cores and with a decreasing ratio of EC to HPMC in the films. Increasing the amount of L-HPC in the cores, which induced a considerable expansion of the fine granules owing to their taking up of water from the dissolution medium, resulted in burstin of the film after a short lag time. The bioavailability of the film-coated fine granules containing 20% SPFX and 52% L-HPC in the cores and 10% EC/HPMC (4/2) in the coating film, which masked the bitter taste of SPFX and showed the optimal release characteristics, was equivalent to that of conventional tablets containing 100 mg SPFX in beagle dogs.
- 社団法人日本薬学会の論文
- 1993-02-15
著者
-
中村 康彦
大日本製薬株式会社製品研究所
-
藤岡 弘
大日本製薬・製品研究所
-
白井 寿海
大日本製薬株式会社製品研究所
-
十川 清己
大日本製薬・製品研究所
-
白井 寿海
Pharmaceutical Research Laboratories, Dainippon Pharmaceutical Co., Ltd.
-
十川 清己
Pharmaceutical Research Laboratories, Dainippon Pharmaceutical Co., Ltd.
-
藤岡 弘
Pharmaceutical Research Laboratories, Dainippon Pharmaceutical Co., Ltd.
-
中村 康彦
Pharmaceutical Research Laboratories, Dainippon Pharmaceutical Co., Ltd.
-
牧田 浩和
Pharmaceutical Research Laboratories, Dainippon Pharmaceutical Co., Ltd.,
-
牧田 浩和
Pharmaceutical Research Laboratories Dainippon Pharmaceutical Co. Ltd.
関連論文
- 難溶性薬物である脳血管障害治療薬(AJ-3941)の固体分散体顆粒の調製とその評価
- テープ接着法による素錠の接着強度とフィルム接着性の評価
- 溶解度積を用いた注射剤の輸液との配合性予測
- 破壊型速溶性コーチング散の苦味マスクと溶出への崩壊剤と熱処理の影響
- サイリウムハスクを用いたマトリックス錠からの薬物放出挙動
- Role of Low-Substituted Hydroxypropylcellulose in Dissolution and Bioavailability of Novel Fine Granule System for Masking Bitter Taste
- A Novel Fine Granule System for Masking Bitter Taste
- Particle Design of Enoxacin by Spherical Crystallizaion Technique. II. Characteristics of Agglomerated Crystals
- Particle Design of Enoxacin by Spherical Crystallization Technique. I. : Principle of Ammonia Diffusion System (ADS)
- Influence of Specific Gravity and Food on Movement of Granules in the Gastrointestinal Tract of Rats
- 糖衣錠の経時的な着色の原因と対策
- Movement of Granules and Tablets in the Gastrointestinal Tract of Gastric-Emptying-Controlled Rabbits
- 凍結乾燥注射剤の溶状不良の原因
- Suitable Size of Preparations to Evaluate the Bioavailability of Enteric-Coated Preparations by the Use of Gastric-Acidity-Controlled Rabbits
- Influence of Pharmaceutical Properties on Gastric Lesions Induced in Rats by AD-1590,a Non-steroidal Anti-inflammatory Drug
- Controlled Release by Ca^-Sensitive Recombinant Human Tumor Necrosis Factor-α Liposomes
- Cryoprotective Effect of Gelatin and Albumin on Recombinant Human Tumor Necrosis Factor Liposome
- ニトロフラン誘導体のシステイン, 消化管内容物および光に対する安定性
- 螢光法によるニトロフラン誘導体の定量
- 苦味をマスクした膜破壊型コーティング細粒の製剤設計に関する研究 : スパルフロキサシン細粒の製剤化
- Design of Novel Controlled-Release Suppositories Containing Polyglycerol Ester of Fatty Acid
- Influence of Solid Fat Index in Triglyceride Suppository Bases on Drug Release
- 苦みのマスキングと徐放製剤
- 第20回粉体に関する討論会